Corline Biomedical AB Free Cash Flow Generation Index
Corline Biomedical AB free cash flow generation index. Corline Biomedical AB (CLBIO) has a Free Cash Flow Generation Index of 0.85x as of June 2026. Free cash flow of Skr104.00K represents 1% of operating cash flow (Skr122.00K). Check Corline Biomedical AB asset resilience ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Corline Biomedical AB (2023–2023)
Free cash flow generation index of Corline Biomedical AB from 2023 to 2023. Historical FCF Generation Index trend for Corline Biomedical AB across 1 annual periods. Explore Corline Biomedical AB (CLBIO) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Corline Biomedical AB Free Cash Flow Generation Index by Year (2023–2023)
Corline Biomedical AB free cash flow generation index by year from 2023 to 2023. Year-by-year Free Cash Flow Generation Index for Corline Biomedical AB. For the full cash flow conversion analysis, see cash flow conversion of Corline Biomedical AB.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -10.99x | Skr-9.73 Million | Skr886.00K | Skr10.62 Million | — |